Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
ADAPT trial
Description:
ADAPT is an acronym used for multiple clinical trials, and the specific trial cannot be identified from the supplied titles.
Related topics:
Myasthenia Gravis and Thymoma (13%),
Traumatic Brain Injury and Neurovascular Disturbances (8%),
Breast Cancer Treatment Studies (8%),
Alzheimer's disease research and treatments (7%)
OpenAlex ID:
keywords/adapt-trial
Clinical and Psychosocial Predictors of Suicide Attempts and Nonsuicidal Self-Injury in the Adolescent Depression Antidepressants and Psychotherapy Trial (ADAPT)
2011
·
Paul Wilkinson
, Raphael Kelvin
, et al.
·
American Journal of Psychiatry
·
749
Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib
2008
·
ADAPT Research Group*
·
Archives of Neurology
·
441
PDF
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
2007
·
Jeffrey L. Cummings
, Rachelle Doody
, et al.
·
Neurology
·
313
Are NSAIDs useful to treat Alzheimer’s disease or mild cognitive impairment?
2010
·
Imbimbo
·
Frontiers in Aging Neuroscience
·
285
PDF
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study
2022
·
Pratik Choudhary
, Ralf Kolassa
, et al.
·
The Lancet Diabetes & Endocrinology
·
220
Cardiovascular and Cerebrovascular Events in the Randomized, Controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)
2006
·
ADAPT Research Group
·
PLoS Clinical Trials
·
205
PDF
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2- and Hormone Receptor–Positive Phase II Randomized Trial—Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET
2017
·
Nadia Harbeck
, Oleg Gluz
, et al.
·
Journal of Clinical Oncology
·
159
A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial
2008
·
I Goodyer
, B Dubicka
, et al.
·
Health Technology Assessment
·
157
PDF
Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis: The ADAPT Randomized Clinical Trial
2019
·
Susan Chan
, Victoria Cornelius
, et al.
·
Archives of Pediatrics and Adolescent Medicine
·
149
PDF
Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort
2008
·
D. Sparks
, Richard Kryscio
, et al.
·
Current Alzheimer Research
·
131
The Effect of Randomization to Weight Loss on Total Mortality in Older Overweight and Obese Adults: The ADAPT Study
2010
·
M. K. Shea
, D. K. Houston
, et al.
·
The Journals of Gerontology Series A
·
117
PDF
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–): survival outcomes from a multicentre, open-label, randomised, phase 2 trial
2022
·
Ulrike Nitz
, Oleg Gluz
, et al.
·
The Lancet Oncology
·
107
Inflammatory cytokines mediate the effects of diet and exercise on pain and function in knee osteoarthritis independent of BMI
2019
·
J. Runhaar
, D.P. Beavers
, et al.
·
Osteoarthritis and Cartilage
·
83
The Cardiovascular Toxicity of Selective and Nonselective Cyclooxygenase Inhibitors: Comparisons, Contrasts, and Aspirin Confounding
2005
·
Panagiotis A. Konstantinopoulos
, David F. Lehmann
·
The Journal of Clinical Pharmacology
·
74
Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT)
2023
·
Francesco Saccà
, Carolina Barnett
, et al.
·
Journal of Neurology
·
63
Treated depression in adolescents: predictors of outcome at 28 weeks
2009
·
Paul Wilkinson
, Bernadka Dubicka
, et al.
·
The British Journal of Psychiatry
·
58
PDF
Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use
2023
·
Young-A Heo
·
CNS Drugs
·
53
PDF
Soothing the Inflamed Brain: Effect of Non-Steroidal Anti-Inflammatory Drugs on Alzheimers Disease Pathology
2011
·
J. J.M. Hoozemans
, R. Veerhuis
, et al.
·
CNS & Neurological Disorders - Drug Targets
·
53
Cholesterol and Cognitive Performance in Normal Controls and the Influence of Elective Statin Use after Conversion to Mild Cognitive Impairment: Results in a Clinical Trial Cohort
2010
·
D. Larry Sparks
, Richard J. Kryscio
, et al.
·
Neurodegenerative Diseases
·
49
PDF
Challenges and opportunities for pediatric severe TBI—review of the evidence and exploring a way forward
2017
·
for the Investigators of the ADAPT Study,
, Michael J. Bell
, et al.
·
Child s Nervous System
·
47
Drug Insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk—where are we now?
2005
·
Gary Spektor
, Valentin Fuster
·
Nature Clinical Practice Cardiovascular Medicine
·
44
Staging anti-inflammatory therapy in Alzheimer’s disease
2010
·
Mathieu P. Lichtenstein
, Paulina Carriba
, et al.
·
Frontiers in Aging Neuroscience
·
43
PDF
The organisational value of diagnostic strategies using high-sensitivity troponin for patients with possible acute coronary syndromes: a trial-based cost-effectiveness analysis
2017
·
Paul Jülicher
, Jaimi H Greenslade
, et al.
·
BMJ Open
·
42
PDF
IAGG Workshop: Health promotion program on prevention of late onset dementia
2011
·
S. Andrieu
, I. Aboderin
, et al.
·
The journal of nutrition health & aging
·
41
p53 Expression in Luminal Breast Cancer Correlates With TP53 Mutation and Primary Endocrine Resistance
2023
·
Sophie Mueller
, Isabel Grote
, et al.
·
Modern Pathology
·
37
PDF
Show more works
View as search
Works count:
187
Citation count:
4,075
Year
Topic
Type